Received May 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
I experienced a rise with blood pressure with the first Shingles; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of increased blood pressure in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced increased blood pressure (Verbatim: I experienced a rise with blood pressure with the first Shingles). The outcome of the increased blood pressure was not reported. It was unknown if the reporter considered the increased blood pressure to be related to Shingrix. It was unknown if the company considered the increased blood pressure to be related to Shingrix. Additional Information: GSK receipt date: 16-MAY-2025 Patient stated that they experienced a rise with blood pressure with the first Shingrix vaccine. Patient was hesitate to take the second shot.
Test Name: rise in blood pressure; Result Unstructured Data: (Test Result:elevated,Unit:unknown,Normal Low:,Normal High:)